2018 HSRPP Conference: University of Newcastle

The booking deadline for HSRPP 2018 is 23/03/2018


The 24th HSRPP conference will be hosted by the University of Newcastle and will be held on April 12th and 13th. The conference theme is:

‘Innovative Healthcare in the 21st Century: Providing smarter, safer, and patient-centred health services’

“Health Information Technology is one of the most rapidly growing areas in health and an essential part of how we diagnose, monitor and treat patients. It can play a major role in improving the safety and quality of health care we provide as leaders and practitioners, and in empowering patients. We welcome research that evaluates novel devices and technologies, and explores new ways of providing more smarter, safer and patient-centred health services. Newcastle University is proud to host the 24th HSRPP Conference and provide a setting for us to meet, learn and share new knowledge about improving the care that we provide and the environment we do it in.”

Conference Chairs: Sarah Slight and Andrew Husband

Dinner: Please note that delegates attending the dinner will be required to present proof of age, if the delegate looks under 25 years of age.

HSRPP 2018 Programme Schedule

N.B. The HSRPP programme schedule will be updated with any changes as they arise, so please regularly check the programme to ensure you are aware of when your abstract is scheduled for.


HSRPP 2018 Presenters

Keynote Speakers

Prof. Paul S. Little

Prof. Paul S. Little M.D., M.Sc., FMedSci is Professor of Primary Care Research at the University of Southampton, and considered one of the most experienced, clinical investigators and trialists in the U.K. He is Director of the NIHR Programme Grants for Applied Research Board, a body that commissions and funds research with an annual budget of £35 million. He has served as a member of the Medical Research Council (MRC) College of Experts (reviews MRC funding proposals), the MRC Health Services and Public Health Research Board (reviews RCTs for complex interventions), and the MRC Efficacy and Mechanism Evaluation Board (decides on investment for late phase clinical trials). He was part of the MRC working group on the future of clinical trials, the MRC working group on the implications of the EU clinical trials directive, and an advisor to the House of Lords and the U.S. Agency for Health Care Policy and Research. He was chairman of the European General Practice Respiratory Infections Network for three years. He was elected to the Research Assessment Exercise (RAE)  panel in 2008 and again to the Research Excellence Framework (REF) panel in 2013  to assess the quality of research activity at eligible U.K. Higher Education Institutions.

Prof. Little has been awarded almost £20 million in grant funding as principal investigator. His current research programme covers two main areas: health promotion (particularly the empowerment and enhanced of self management for chronic disease) and the management of common self-limiting illnesses. These topics link evidence about the effectiveness of clinical management strategies with the management of patients and practitioners’ beliefs and behaviour, as well as with the development of a better understanding of patient-centred approaches to the consultation. Prof. Little has recently gained funding for three major Programmes to develop behavioural interventions in the areas of nutrition, cognitive impairment and cancer survivorship following the successful completion of several trials using predominantly web based behavioural support (e.g. the GRACE INTRO trial to reduce antibiotic prescription; HTA POWeR2 trial for obesity; and  the MRC PRIMIT trial for preventing transmission of infections within families). He also supports several other similar studies in the Southampton group (including for eczema, hypertension, back pain and irritable bowel), and is PI of the CANDID cohort which has recruited more than 20,000 individuals to develop clinical prediction rules for lung and colon cancer (the NIHR School for Primary Care Research CANDID study).


Prof. Aziz Sheikh

Aziz Sheikh is Professor of Primary Care Research and Development and Co-Director of the Centre of Medical Informatics in the Usher Institute of Population Health Sciences at The University of Edinburgh. He will take over directorship of the Usher Institute of Population Health Sciences and Informatics from August 2017. Aziz has substantive academic and health policy interests in leveraging the potential of health information technology and data science to transform the delivery of health care and improve population health, which have led him to work with numerous governments, the World Health Organization (WHO) and the World Bank.  He serves on the Steering Group and as Chair of the Evaluation Group of the WHO’s 3rd Global Safety Challenge on Medication Safety as adviser to its Eastern Mediterranean Regional Office.

He is an editorial board member of PLOS Medicine, Medical Care, Health Informatics Journal and BMC Medicine, and Editor-in-Chief of Nature Partnership Journal: Primary Care Respiratory Medicine.

Aziz has, together with colleagues across the world, held research grants in excess of £50m, has over 950 peer-reviewed publications, and over 37,000 citations to his work. His co-edited books include Health Care Errors and Patient Safety (Wiley), Patient Safety and Healthcare Improvement at a Glance (Wiley) and Key Advances in Clinical Informatics: Transforming Health Care through Health Information Technology (Elsevier).  He has given keynote and plenary presentations in over 40 countries and has won numerous national fellowships and awards including, most recently, a Harkness Fellowship in Health Policy and Practice based at Brigham and Women’s Hospital/Harvard Medical School.  He held the position of Visiting Professor of Medicine at Brigham and Women’s Hospital/Harvard Medical School (2014-16) and currently holds visiting chairs at the University of Birmingham (UK), Queen Mary’s University of London (UK) and Maastricht University (Netherlands).

Aziz holds fellowships from 7 learned societies and he was made an Officer of the Order of the British Empire for Services to Medicine and Health Care by Her Majesty Queen Elizabeth II in 2014.

Prof. Bryony Dean Franklin

Bryony Dean Franklin BPharm MSc PhD FRPS FRPharmS is Director of the Centre for Medication Safety and Service Quality, a joint initiative between Imperial College Healthcare NHS Trust and UCL School of Pharmacy where she is Professor of Medication Safety. She is Visiting Professor at Imperial College School of Medicine, where she leads a research theme within each of the NIHR Imperial Patient Safety Translational Research Centre and the NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance. She is Executive Lead Pharmacist for Research at Imperial College Healthcare NHS Trust, a role that involves leading patient safety-related research, teaching and clinical practice, associate editor for the journal BMJ Quality and Safety, and on the editorial board for BMC Safety in Health.

Prof. Franklin is an internationally recognised leader in medication error research. Her research portfolio includes studies on the incidence and causes of various types of medication errors, as well as the development of a validated method for assessing the clinical significance of these errors. She led the first study of the incidence and causes of prescribing errors in a UK hospital (published in The Lancet), and has conducted evaluations of a range of technologies and their effects on medication safety, as well as how we can support the public role in patient safety. She is co-editor of the textbook “Safety in Medication Use” and co-author of “Going into Hospital?  A guide for patients, carers and families”, a book aimed at the general public.


Watch the video below to see what Newcastle has to offer!